Results announced in December 2025 confirmed the Phase 2 findings at a longer timepoint (Lilly Press Release, Dec 2025): The 28.7% weight loss at 68 weeks exceeds both semaglutide (~15% in STEP trials) and tirzepatide (~22.5% in SURMOUNT trials) at similar timepoints
Medically termed delayed gastric emptying, this effect contributes to feeling fuller for longer, which supports weight loss, but it also has profound implications for digestion
Each one can reduce potency, introduce contamination, or render your entire vial useless
I mean, there are just some incredible numbers that we've seen emerging, as it relates to the hyperscaler investment that we're seeing in building out the infrastructure
PEG 3350 is known as an osmotic laxative
Most patients peptide therapy plans last between 4 and 6 weeks, but the length of your program and the frequency of injections depend on your goals and the chosen peptides